HRT Financial’s Medifast MED Stock Holding History

HRT Financial’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-115,426	Closed	-$2.52M	–	2847
2024 Q2	$2.52M	Buy	+115,426	New	+$3.08M	0.01%	646
2023 Q4	–	Sell	-6,899	Closed	-$516K	–	2773
2023 Q3	$516K	Buy	+6,899	New	+$612K	0.01%	1390
2023 Q2	–	Sell	-18,746	Closed	-$1.94M	–	2935
2023 Q1	$1.94M	Buy	18,746 +13,160	+236%	+$1.46M	0.02%	610
2022 Q4	$644K	Buy	+5,586	New	+$650K	0.01%	1245
2022 Q3	–	Sell	-6,530	Closed	-$1.18M	–	3229
2022 Q2	$1.18M	Sell	6,530 -15,785	-71%	-$2.82M	0.01%	816
2022 Q1	$3.81M	Buy	22,315 +19,807	+790%	+$3.73M	0.03%	366
2021 Q4	$525K	Sell	2,508 -4,583	-65%	-$947K	﹤0.01%	1716
2021 Q3	$1.37M	Buy	7,091 +2,761	+64%	+$679K	0.01%	1008
2021 Q2	$1.23M	Buy	+4,330	New	+$1.17M	0.01%	896
2019 Q1	–	Sell	-2,101	Closed	-$262K	–	681
2018 Q4	$262K	Buy	+2,101	New	+$359K	0.04%	401

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's MED Position: Q3 2024 in Review

HRT Financial sold out of Medifast (MED) in Q3 2024, closing a stake of 115,426 shares — an estimated $2.52M sold.

HRT Financial first reported a position in MED in Q4 2018 and held it in 10 quarters. The position peaked at $3.81M in Q1 2022. 140 funds tracked by Wall St. Rank hold MED as of Q3 2024.

HRT Financial reported no remaining Medifast position as of Q3 2024 after selling out during the quarter.
HRT Financial sold 115,426 Medifast shares in Q3 2024, an estimated $2.52M.
HRT Financial first reported a position in Medifast in Q4 2018 and held it in 10 quarters.
HRT Financial's Medifast position peaked at $3.81M in Q1 2022.
140 funds tracked by Wall St. Rank held Medifast as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.